Abstract:The lack of organs for transplantation is an important problem in medicine today. The growth of organs in chimeric animals may be the solution of this. The proposed technology is the interspecific blastocyst complementation method in combination with genomic editing for obtaining "free niches" and pluripotent stem cell production methods. The CRISPR/Cas9 method allows the so-called "free niches" to be obtained for blastocyst complementation. The technologies of producing induced pluripotent stem cells give us the opportunity to obtain human donor cells capable of populating a "free niche". Taken together, these technologies allow interspecific blastocyst complementation between humans and other animals, which makes it possible in the future to grow human organs for transplantations inside chimeric animals. However, in practice, in order to achieve successful interspecific blastocyst complementation, it is necessary to solve a number of problems: to improve methods for producing "chimeric competent" cells, to overcome specific interspecific barriers, to select compatible cell developmental stages for injection and the corresponding developmental stage of the host embryo, to prevent apoptosis of donor cells and to achieve effective proliferation of the human donor cells in the host animal. Also, it is very important to analyze the ethical aspects related to developing technologies of chimeric organisms with the participation of human cells. Today, many researchers are trying to solve these problems and also to establish new approaches in the creation of interspecific chimeric organisms in order to grow human organs for transplantation. In the present review we described the historical stages of the development of the blastocyst complementation method, examined in detail the technologies that underlie modern blastocyst complementation, and analyzed current progress that gives us the possibility to grow human organs in chimeric animals. We also considered the barriers and issues preventing the successful implementation of interspecific blastocyst complementation in practice, and discussed the further development of this method.

Growth Competition in Interspecies Chimeras: A New Paradigm for Blastocyst Complementation

Generation of Functional Organs Using a Cell-Competitive Niche in Intra- and Inter-species Rodent Chimeras

Generation of donor organs in chimeric animals via blastocyst complementation

Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism

The road to generating transplantable organs: from blastocyst complementation to interspecies chimeras

Xenogeneic chimera-Generated by blastocyst complementation-As a potential unlimited source of recipient-tailored organs

Cell competition constitutes a barrier for interspecies chimerism

Interspecies Chimerism with Mammalian Pluripotent Stem Cells.

Hopes and Difficulties for Blastocyst Complementation

Interspecies chimeras for human stem cell research

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research

[Interspecies systemic chimeras]

Chimerism as the basis for organ repair

In vitro and in vivo functions of T cells produced in complemented thymi of chimeric mice generated by blastocyst complementation

Mouse chimeras as a system to investigate development, cell and tissue function, disease mechanisms and organ regeneration

Stem Cells and Interspecies Chimaeras

Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cells

Generating Functional Cells Through Enhanced Interspecies Chimerism with Human Pluripotent Stem Cells

Towards human organ generation using interspecies blastocyst complementation: Challenges and perspectives for therapy

An Alternative Pluripotent State Confers Interspecies Chimaeric Competency.

Paracrine interactions through FGFR1 and FGFR2 receptors regulate the development of preimplantation mouse chimaeric embryo